Clinical trial
N-homocysteinylated Huntingtin in Huntington's Disease
NCT05225051 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- N-homocysteinylated Huntingtin in Huntington's Disease
- Lead sponsor
- Central Hospital, Nancy, France
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 1, 2022
- Completion date
- May 1, 2023
- Enrollment
- 32 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.